The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Immunotherapeutic Drugs Market Research Report 2025
Synopsis
Immunotherapy is a cancer treatment that enhances the body's natural defenses against cancer-fighting tissues.In this treatment, substances made in the body or laboratory are used to improve or restore immune system function.The drugs used in this treatment are called immunotherapeutics.Immunotherapy drugs are designed to warn the immune system about mutated cells, so it can easily find and destroy them.
The global Immunotherapeutic Drugs market was valued at US$ 177160 million in 2023 and is anticipated to reach US$ 379440 million by 2030, witnessing a CAGR of 11.3% during the forecast period 2024-2030.
North American market for Immunotherapeutic Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Immunotherapeutic Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Immunotherapeutic Drugs in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Immunotherapeutic Drugs include Roche, Merck, Novartis, Johnson & Johnson, GlaxoSmithKline, AbbVie, ELI Lilly, Amgen and AstraZeneca, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Immunotherapeutic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunotherapeutic Drugs.
Report Scope
The Immunotherapeutic Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Immunotherapeutic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immunotherapeutic Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Merck
Novartis
Johnson & Johnson
GlaxoSmithKline
AbbVie
ELI Lilly
Amgen
AstraZeneca
Bristol-Mysers Squibb
Segment by Type
Monoclonal Antibody
Vaccines
Checkpoint Inhibitor
Interferon
Segment by Application
Hospitals
Clinics
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immunotherapeutic Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Immunotherapy is a cancer treatment that enhances the body's natural defenses against cancer-fighting tissues.In this treatment, substances made in the body or laboratory are used to improve or restore immune system function.The drugs used in this treatment are called immunotherapeutics.Immunotherapy drugs are designed to warn the immune system about mutated cells, so it can easily find and destroy them.
The global Immunotherapeutic Drugs market was valued at US$ 177160 million in 2023 and is anticipated to reach US$ 379440 million by 2030, witnessing a CAGR of 11.3% during the forecast period 2024-2030.
North American market for Immunotherapeutic Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Immunotherapeutic Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Immunotherapeutic Drugs in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Immunotherapeutic Drugs include Roche, Merck, Novartis, Johnson & Johnson, GlaxoSmithKline, AbbVie, ELI Lilly, Amgen and AstraZeneca, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Immunotherapeutic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunotherapeutic Drugs.
Report Scope
The Immunotherapeutic Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Immunotherapeutic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immunotherapeutic Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Merck
Novartis
Johnson & Johnson
GlaxoSmithKline
AbbVie
ELI Lilly
Amgen
AstraZeneca
Bristol-Mysers Squibb
Segment by Type
Monoclonal Antibody
Vaccines
Checkpoint Inhibitor
Interferon
Segment by Application
Hospitals
Clinics
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immunotherapeutic Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immunotherapeutic Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Monoclonal Antibody
1.2.3 Vaccines
1.2.4 Checkpoint Inhibitor
1.2.5 Interferon
1.3 Market by Application
1.3.1 Global Immunotherapeutic Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immunotherapeutic Drugs Market Perspective (2019-2030)
2.2 Immunotherapeutic Drugs Growth Trends by Region
2.2.1 Global Immunotherapeutic Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Immunotherapeutic Drugs Historic Market Size by Region (2019-2024)
2.2.3 Immunotherapeutic Drugs Forecasted Market Size by Region (2025-2030)
2.3 Immunotherapeutic Drugs Market Dynamics
2.3.1 Immunotherapeutic Drugs Industry Trends
2.3.2 Immunotherapeutic Drugs Market Drivers
2.3.3 Immunotherapeutic Drugs Market Challenges
2.3.4 Immunotherapeutic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immunotherapeutic Drugs Players by Revenue
3.1.1 Global Top Immunotherapeutic Drugs Players by Revenue (2019-2024)
3.1.2 Global Immunotherapeutic Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Immunotherapeutic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immunotherapeutic Drugs Revenue
3.4 Global Immunotherapeutic Drugs Market Concentration Ratio
3.4.1 Global Immunotherapeutic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immunotherapeutic Drugs Revenue in 2023
3.5 Immunotherapeutic Drugs Key Players Head office and Area Served
3.6 Key Players Immunotherapeutic Drugs Product Solution and Service
3.7 Date of Enter into Immunotherapeutic Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immunotherapeutic Drugs Breakdown Data by Type
4.1 Global Immunotherapeutic Drugs Historic Market Size by Type (2019-2024)
4.2 Global Immunotherapeutic Drugs Forecasted Market Size by Type (2025-2030)
5 Immunotherapeutic Drugs Breakdown Data by Application
5.1 Global Immunotherapeutic Drugs Historic Market Size by Application (2019-2024)
5.2 Global Immunotherapeutic Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Immunotherapeutic Drugs Market Size (2019-2030)
6.2 North America Immunotherapeutic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Immunotherapeutic Drugs Market Size by Country (2019-2024)
6.4 North America Immunotherapeutic Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immunotherapeutic Drugs Market Size (2019-2030)
7.2 Europe Immunotherapeutic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Immunotherapeutic Drugs Market Size by Country (2019-2024)
7.4 Europe Immunotherapeutic Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immunotherapeutic Drugs Market Size (2019-2030)
8.2 Asia-Pacific Immunotherapeutic Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Immunotherapeutic Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Immunotherapeutic Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immunotherapeutic Drugs Market Size (2019-2030)
9.2 Latin America Immunotherapeutic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Immunotherapeutic Drugs Market Size by Country (2019-2024)
9.4 Latin America Immunotherapeutic Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immunotherapeutic Drugs Market Size (2019-2030)
10.2 Middle East & Africa Immunotherapeutic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Immunotherapeutic Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Immunotherapeutic Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Immunotherapeutic Drugs Introduction
11.1.4 Roche Revenue in Immunotherapeutic Drugs Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Immunotherapeutic Drugs Introduction
11.2.4 Merck Revenue in Immunotherapeutic Drugs Business (2019-2024)
11.2.5 Merck Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Immunotherapeutic Drugs Introduction
11.3.4 Novartis Revenue in Immunotherapeutic Drugs Business (2019-2024)
11.3.5 Novartis Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Immunotherapeutic Drugs Introduction
11.4.4 Johnson & Johnson Revenue in Immunotherapeutic Drugs Business (2019-2024)
11.4.5 Johnson & Johnson Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Immunotherapeutic Drugs Introduction
11.5.4 GlaxoSmithKline Revenue in Immunotherapeutic Drugs Business (2019-2024)
11.5.5 GlaxoSmithKline Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Detail
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Immunotherapeutic Drugs Introduction
11.6.4 AbbVie Revenue in Immunotherapeutic Drugs Business (2019-2024)
11.6.5 AbbVie Recent Development
11.7 ELI Lilly
11.7.1 ELI Lilly Company Detail
11.7.2 ELI Lilly Business Overview
11.7.3 ELI Lilly Immunotherapeutic Drugs Introduction
11.7.4 ELI Lilly Revenue in Immunotherapeutic Drugs Business (2019-2024)
11.7.5 ELI Lilly Recent Development
11.8 Amgen
11.8.1 Amgen Company Detail
11.8.2 Amgen Business Overview
11.8.3 Amgen Immunotherapeutic Drugs Introduction
11.8.4 Amgen Revenue in Immunotherapeutic Drugs Business (2019-2024)
11.8.5 Amgen Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Detail
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Immunotherapeutic Drugs Introduction
11.9.4 AstraZeneca Revenue in Immunotherapeutic Drugs Business (2019-2024)
11.9.5 AstraZeneca Recent Development
11.10 Bristol-Mysers Squibb
11.10.1 Bristol-Mysers Squibb Company Detail
11.10.2 Bristol-Mysers Squibb Business Overview
11.10.3 Bristol-Mysers Squibb Immunotherapeutic Drugs Introduction
11.10.4 Bristol-Mysers Squibb Revenue in Immunotherapeutic Drugs Business (2019-2024)
11.10.5 Bristol-Mysers Squibb Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
